002294 信立泰
已收盘 08-24 15:00:00
资讯
新帖
简况
图解信立泰中报：第二季度单季净利润同比下降1.78%
证券之星 · 02:23
图解信立泰中报：第二季度单季净利润同比下降1.78%
8月21日信立泰跌5.36%，光大健康优加混合A基金重仓该股
证券之星 · 08-21
8月21日信立泰跌5.36%，光大健康优加混合A基金重仓该股
信立泰（002294）披露SAL012药品临床试验申请获得受理的公告，8月14日股价下跌2.51%
证券之星 · 08-14
信立泰（002294）披露SAL012药品临床试验申请获得受理的公告，8月14日股价下跌2.51%
信立泰最新公告：SAL012临床试验申请获受理
证券之星 · 08-14
信立泰最新公告：SAL012临床试验申请获受理
新股消息 | 信立泰(002294.SZ)港股IPO招股书失效
智通财经 · 08-12
新股消息 | 信立泰(002294.SZ)港股IPO招股书失效
信立泰（002294）披露SAL0195获得临床试验批准通知书，8月7日股价上涨6.44%
证券之星 · 08-07
信立泰（002294）披露SAL0195获得临床试验批准通知书，8月7日股价上涨6.44%
信立泰最新公告：SAL0195获临床试验批准通知书
证券之星 · 08-07
信立泰最新公告：SAL0195获临床试验批准通知书
信立泰（002294）披露回购公司股份进展公告，8月3日股价下跌0.24%
证券之星 · 08-03
信立泰（002294）披露回购公司股份进展公告，8月3日股价下跌0.24%
7月21日信立泰跌5.44%，金信价值精选混合A基金重仓该股
证券之星 · 07-21
7月21日信立泰跌5.44%，金信价值精选混合A基金重仓该股
一图速览Q2基金持仓变化
格隆汇 · 07-21
一图速览Q2基金持仓变化
7月16日信立泰涨7.04%，中欧医疗健康混合A基金重仓该股
证券之星 · 07-16
7月16日信立泰涨7.04%，中欧医疗健康混合A基金重仓该股
7月10日信立泰涨5.45%，中欧医疗健康混合A基金重仓该股
证券之星 · 07-10
7月10日信立泰涨5.45%，中欧医疗健康混合A基金重仓该股
信立泰（002294）披露SAL0167获得临床试验批准通知书，7月8日股价下跌7.0%
证券之星 · 07-08
信立泰（002294）披露SAL0167获得临床试验批准通知书，7月8日股价下跌7.0%
信立泰(002294.SZ)：SAL0167获得临床试验批准
智通财经网 · 07-08
信立泰(002294.SZ)：SAL0167获得临床试验批准
信立泰（002294）披露股票交易异常波动公告，7月3日股价上涨9.99%
证券之星 · 07-03
信立泰（002294）披露股票交易异常波动公告，7月3日股价上涨9.99%
信立泰（002294）披露回购公司股份进展公告，7月1日股价上涨7.24%
证券之星 · 07-01
信立泰（002294）披露回购公司股份进展公告，7月1日股价上涨7.24%
7月1日信立泰涨7.24%，中欧医疗健康混合A基金重仓该股
证券之星 · 07-01
7月1日信立泰涨7.24%，中欧医疗健康混合A基金重仓该股
每周股票复盘：信立泰（002294）首次回购股份999,600股
证券之星 · 06-21
每周股票复盘：信立泰（002294）首次回购股份999,600股
百亿基金经理调仓路径出炉：张坤增聘共管后新布局，葛兰谢治宇反向操作
澎湃新闻 · 06-18
百亿基金经理调仓路径出炉：张坤增聘共管后新布局，葛兰谢治宇反向操作
信立泰（002294）披露首次回购公司股份公告，6月17日股价下跌0.63%
证券之星 · 06-17
信立泰（002294）披露首次回购公司股份公告，6月17日股价下跌0.63%
加载更多
公司概况
公司名称：
深圳信立泰药业股份有限公司
所属行业：
医药制造业
上市日期：
2009-09-10
主营业务：
深圳信立泰药业股份有限公司的主营业务是药品、医疗器械产品的研发、生产、销售，以及专利授权许可。公司的主要产品是心脑血管、肾脏、代谢类药物及医疗器械、骨科药物、头孢类抗生素及原料。
发行价格：
41.98
{"stockData":{"symbol":"002294","market":"SZ","secType":"STK","nameCN":"信立泰","latestPrice":31.62,"timestamp":1787555022000,"preClose":32.68,"halted":0,"volume":20123274,"delay":0,"changeRate":-0.0324,"floatShares":1115000000,"shares":1115000000,"eps":0.6068,"marketStatus":"已收盘","change":-1.06,"latestTime":"08-24 15:00:00","open":32.89,"high":32.99,"low":31.35,"amount":643000000,"amplitude":0.0502,"askPrice":31.63,"askSize":98,"bidPrice":31.62,"bidSize":116,"shortable":0,"etf":0,"ttmEps":0.6068,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787621400000},"marketStatusCode":5,"adr":0,"adjPreClose":32.68,"symbolType":"stock","openAndCloseTimeList":[[1787535000000,1787542200000],[1787547600000,1787554800000]],"highLimit":35.95,"lowLimit":29.41,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1114816535,"isCdr":false,"pbRate":3.98,"roa":"--","peRate":52.109426,"roe":"2.49%","epsLYR":0.58,"committee":0.083238,"marketValue":35250000000,"turnoverRate":0.0181,"status":1,"floatMarketCap":35243000000},"requestUrl":"/m/hq/s/002294","defaultTab":"news","newsList":[{"id":"2662039582","title":"图解信立泰中报：第二季度单季净利润同比下降1.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039582","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662039582?lang=zh_cn&edition=full","pubTime":"2026-08-25 02:23","pubTimestamp":1787595799,"startTime":"0","endTime":"0","summary":"证券之星消息，信立泰2026年中报显示，上半年度公司主营收入24.79亿元，同比上升16.34%；归母净利润3.87亿元，同比上升6.03%；扣非净利润4.01亿元，同比上升15.64%；其中2026年第二季度，公司单季度主营收入12.51亿元，同比上升17.02%；单季度归母净利润1.62亿元，同比下降1.78%；单季度扣非净利润1.8亿元，同比上升16.07%；负债率21.52%，投资收益1508.84万元，财务费用721.07万元，毛利率75.09%。财报数据概要请见下图:本文数据来源于信立泰2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500005359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002294"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661265227","title":"8月21日信立泰跌5.36%，光大健康优加混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661265227","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661265227?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:44","pubTimestamp":1787301841,"startTime":"0","endTime":"0","summary":"证券之星消息，8月21日信立泰跌5.36%，收盘报32.68元，换手率2.76%，成交量30.78万手，成交额10.1亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为光大保德信基金的光大健康优加混合A。光大健康优加混合A目前规模为6.23亿元，最新净值0.8996，较上一交易日上涨4.04%，近一年下跌4.91%。光大健康优加混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100029597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0183","BK0196","BK0239","BK0187","BK0028","002294"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659147891","title":"信立泰（002294）披露SAL012药品临床试验申请获得受理的公告，8月14日股价下跌2.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659147891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659147891?lang=zh_cn&edition=full","pubTime":"2026-08-14 22:03","pubTimestamp":1786716201,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，信立泰报收于34.9元，较前一交易日下跌2.51%，最新总市值为389.07亿元。该股当日开盘35.2元，最高36.07元，最低34.29元，成交额达11.42亿元，换手率为2.92%。近日，深圳信立泰药业股份有限公司及全资子公司收到国家药品监督管理局出具的受理通知书，公司自主研发的创新药“注射用SAL012”临床试验申请已获受理。该药品为1类治疗用生物制品，拟用于治疗晚期实体瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400039502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002294","BK0188","BK0183","BK0196","BK0028","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659011792","title":"信立泰最新公告：SAL012临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2659011792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659011792?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:26","pubTimestamp":1786699617,"startTime":"0","endTime":"0","summary":"信立泰(002294.SZ)公告称，公司及全资子公司收到国家药品监督管理局出具的受理通知书，自主研发的1类创新药“注射用SAL012”临床试验申请获得受理。该药品为治疗用生物制品，用于治疗晚期实体瘤。临床前研究显示，SAL012具有剂量依赖性抑制肿瘤生长的潜力，安全性、耐受性良好。若研发成功并获批上市，将为晚期实体瘤患者提供新的用药选择。该产品短期内对公司业绩不会产生实际影响。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。相关 ETF","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400029155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002294","BK0188","BK0187","BK0183","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658094925","title":"新股消息 | 信立泰(002294.SZ)港股IPO招股书失效","url":"https://stock-news.laohu8.com/highlight/detail?id=2658094925","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658094925?lang=zh_cn&edition=full","pubTime":"2026-08-12 06:35","pubTimestamp":1786487738,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，深圳信立泰药业股份有限公司于2026年2月12日所递交的港股招股书满6个月，于2026年8月12日失效，递表时高盛、花旗、中信证券为其联席保荐人。据此前招股书，信立泰是中国心血管-肾脏-代谢疾病治疗领域的先行者。截至最后实际可行日期，根据弗若斯特沙利文的资料，公司拥有按规模计国内企业中第二大的心肾代谢综合征创新药管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478735.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","KCAI","BK0183","002294","BK0187","KCE","BK4588","BK0188","BK0239","REDS","VXUS","BK4585","FRHC","BK0028","BK0196","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657564175","title":"信立泰（002294）披露SAL0195获得临床试验批准通知书，8月7日股价上涨6.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657564175","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657564175?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:04","pubTimestamp":1786111462,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，信立泰报收于36.03元，较前一交易日上涨6.44%，最新总市值为401.67亿元。该股当日开盘33.81元，最高36.08元，最低33.8元，成交额达14.42亿元，换手率为3.69%。近日，深圳信立泰药业股份有限公司收到国家药品监督管理局核准签发的《临床试验批准通知书》，同意公司自主研发的创新siRNA药物SAL0195注射液开展治疗脂蛋白增高的临床试验。公司将按相关规定开展临床试验，后续进展将及时披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700040492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0196","BK0183","002294","BK0187","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657123246","title":"信立泰最新公告：SAL0195获临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2657123246","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657123246?lang=zh_cn&edition=full","pubTime":"2026-08-07 18:10","pubTimestamp":1786097423,"startTime":"0","endTime":"0","summary":"信立泰(002294.SZ)公告称，公司收到国家药监局核准签发的《临床试验批准通知书》，同意公司自主研发的创新siRNA药物SAL0195注射液开展治疗脂蛋白(a)增高的临床试验。该药物在临床前猴模型中具有单次给药持续140天的靶点敲除长效作用，有望为患者提供新的用药选择，并丰富公司慢病领域创新产品管线。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700033511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0187","BK0196","002294","BK0188","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656724372","title":"信立泰（002294）披露回购公司股份进展公告，8月3日股价下跌0.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656724372","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656724372?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:09","pubTimestamp":1785766157,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，信立泰报收于33.2元，较前一交易日下跌0.24%，最新总市值为370.12亿元。该股当日开盘33.28元，最高33.65元，最低33.01元，成交额达4.96亿元，换手率为1.34%。近日，信立泰发布关于回购公司股份的进展公告。公告显示，公司于2026年5月29日召开董事会，审议通过回购公司股份的议案，拟以自有资金及自筹资金回购A股股份，资金总额不低于30,000万元且不超过50,000万元，回购价格不超过45元/股。回购股份用于股权激励或员工持股计划。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300036810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0196","BK0188","002294","BK0028","BK0183","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653220235","title":"7月21日信立泰跌5.44%，金信价值精选混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653220235","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653220235?lang=zh_cn&edition=full","pubTime":"2026-07-21 16:47","pubTimestamp":1784623662,"startTime":"0","endTime":"0","summary":"证券之星消息，7月21日信立泰跌5.44%，收盘报35.28元，换手率5.23%，成交量58.26万手，成交额20.4亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为金信基金的金信价值精选混合A。金信价值精选混合A目前规模为0.17亿元，最新净值1.9273，较上一交易日上涨3.56%，近一年上涨114.44%。金信价值精选混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100030848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0183","BK0187","BK0188","002294","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653202224","title":"一图速览Q2基金持仓变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2653202224","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653202224?lang=zh_cn&edition=full","pubTime":"2026-07-21 15:24","pubTimestamp":1784618670,"startTime":"0","endTime":"0","summary":"26Q2基金持仓有何变化？","market":"us","thumbnail":"https://img3.gelonghui.com/34bf1-b33c39e9-b6f2-4740-8eff-6f1bd2e8225c.jpg?guru_height=700&guru_width=1000&guru_size=105573","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/34bf1-b33c39e9-b6f2-4740-8eff-6f1bd2e8225c.jpg?guru_height=700&guru_width=1000&guru_size=105573"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/5670484","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU2506951792.HKD","LU0326948709.USD","BK4587","HK0000151867.HKD","BK4548","BK1614","LU0329678337.USD","LU1961090484.USD","KWEB","688347","LU0541502299.USD","LU0043850808.USD","LU0080751232.USD","LU1064130708.USD","300750","IE00BZ199S13.USD","01888","LU3227948356.SGD","LU0269904917.USD","LU0117841782.USD","BK4504","BABA","LU0823413660.USD","LU0289960550.SGD","LU0293314216.USD","LU1328615791.USD","TCEHY","LU1956131251.USD","LU0203345920.USD","LU2298321311.HKD","BK1609","FFEM","BK4531","LU1152091168.USD","LU0531970944.HKD","LU0607220059.USD","LU0823437842.USD","LU1719994722.HKD","SG9999014906.USD","LU1196710864.SGD","LU0196878994.USD","LU0266512127.USD","LU2495084118.USD","LU1316542783.SGD","SG9999014674.SGD","IE00BZ08YS42.EUR","BK0076","LU0791590937.USD","LU2153592121.USD","LU2476274720.SGD","LU1770036033.HKD","LU0633140560.USD","HK0000306685.HKD","LU0181495838.USD","LU0594300419.USD","LU2092937221.SGD","300308","LU0823397285.USD","HK0000352382.USD","BK4220","SG9999001093.SGD","LU2238339852.HKD","002294","BK4607","LU0188438112.USD","LU0886674414.USD","LU1868837565.USD","LU1861219969.SGD","LU1003077747.HKD","80883","LU0724618433.USD","ESPO","IE00BMCWC346.EUR","LU0345770308.USD","IE0032834883.USD","LU0320764599.SGD","BK1589","LU0192582467.USD","LU0823038988.USD","LU0052750758.USD","LU0348788117.USD","SG9999000418.SGD","BK1615","IE00BD6J9T35.USD","SG9999014914.USD","IE0001KFT4U8.USD","LU0823040885.USD","688256","LU0052756011.USD","LU1861214812.USD","LU2298322129.HKD","LU0310800965.SGD","LU0127658192.USD","SG9999015986.USD","IE00BZ08YR35.GBP","LU1988902786.USD","IE0032431581.USD","LU1282651121.HKD","LU1734074674.USD","LU0384037296.USD","LU0449515922.USD","LU1794554557.SGD","LU1046422090.SGD","BK1608","LU0345770993.USD","09988","HK0001040143.USD","HK0000181138.USD","LU1969619763.USD","LU1226287792.SGD","LU0633140727.USD","LU2153591404.USD","SG9999015952.SGD","JADE","LU0594300179.USD","SGXZ31699556.SGD","IE00BF5LJ272.USD","LU0501845795.SGD","LU2148510915.USD","LU1993786604.SGD","BK0188","LU1655091459.SGD","LU1820825898.SGD","BK1516","LU2065171311.SGD","LU2265009873.SGD","LU1282651048.USD","BK4538","LU1974910355.USD","LU0672654166.SGD","LU0396098781.USD","LU0873338254.USD","IE00BMPRXN33.USD","LU0251143458.SGD","BBYY","LU0359201885.HKD","LU1046421795.USD","LU1282649067.USD","LU0228367735.SGD","LU0067412154.USD","IE00B0JY6N72.USD","LU1224444064.USD","SG9999003461.SGD","BK0141","IE00B97KM107.HKD","LU0048580855.USD","LU0819123356.HKD","LU1115378108.SGD","LU1481107354.HKD","IE0003895053.USD","LU0543330483.HKD","LU2462611646.USD","SG9999011746.SGD","LU0211977185.USD","LU1102505762.USD","LU0128522157.USD","LU0259732245.USD","KBAB","LU0878004406.USD","MCHS","LU0823426308.USD","LU1196710195.USD","LU0642271901.SGD","LU0417516902.SGD","LU2362540622.SGD","LU1048484197.HKD","IE00B031J352.USD","LU0072913022.USD","SG9999017495.SGD","BK1502","LU2045819591.USD","LU1255011170.USD","LU1934453819.USD","LU0163747925.USD","BK0183","BK4581","BK1521","IE0008368411.USD","IE00B0169L03.USD","LU0047713382.USD","BK4524","HK0000181112.HKD","LU0261950470.USD","LU1044874839.SGD","002384","601899","LU0588545490.SGD","BK0070","LU0251144936.SGD","LU0048597586.USD","LU1769817179.HKD","LU0831103253.SGD","LU0455707207.USD","LU0244354667.USD","HK0000914686.HKD","LU0164939612.USD","LU1960683339.HKD","LU2177674079.SGD","LU0414403682.SGD","BK0187","LU0106959298.USD","BK1517","LU2460026573.USD","BK1505","SG9999002562.SGD","LU1235294995.USD","LU0143863198.USD","BK4535","LU1642822792.SGD","LU0096374516.USD","LU1823568750.SGD","LU0738912210.USD","LU1282649810.SGD","IE00BQXX3C00.GBP","LU0543330566.HKD","LU0620787316.HKD","LU0589944569.HKD","HK0000320223.HKD","BK1095","LU0049112450.USD","LU0456854461.SGD","BK0152","LU1804176565.USD","LU2249611893.SGD","LU0203347892.USD","BABO","LU0577902371.SGD","LU1504937902.USD","LU1770034418.SGD","SGXZ49509284.SGD","BK0148","BK0069","LU0082770016.SGD","LU1634259557.SGD","LU0328353924.USD","LU2399975544.HKD","BK1607","IE00BPRC5H50.USD","LU0287142896.SGD","BK4554","LU1808992512.USD","LU1883866441.USD","LU0261947096.USD","SG9999004220.SGD","LU0890818403.SGD","LU0821914370.USD","LU0505663152.USD","LU0708995153.HKD","BK0102","LU0229945570.USD","LU0516423091.SGD","LU2328871848.SGD","LU1814569148.SGD","LU1725190679.HKD","BK1198","LU1251922891.USD","GAMR","LU2317271919.USD","01347","LU1781817850.SGD","BK1610","LU2424517915.HKD","LU0577902538.SGD","LU0359201612.USD","LU1023057109.AUD","LU0345780281.USD","LU2226246903.HKD","SG9999018865.SGD","LU2087589342.USD","LU0541501648.USD","LU0449509016.USD","LU0469268626.HKD","LU0327786744.USD","LU1105468828.SGD","LU0823426480.USD","LU2348774022.SGD","LU2237443549.SGD","TCHI","LU0312595415.SGD","IE00BGV7N243.SGD","LU0214875030.USD","LU0871576103.HKD","LU0880133367.SGD","LU2506952337.HKD","LU0348723411.USD","LU0210526637.USD","LU0345769631.USD","BK0028","LU1880383440.USD","BK1170","LU2237443382.USD","ODDS","BK4558","BK1586","LU0882747503.HKD","LU2275660780.HKD","LU2023250504.SGD","IE00BMPRXR70.SGD","IE0031814852.USD","BK1544","LU0348825331.USD","LU1497733557.USD","LU0370786039.SGD","LU0651946864.USD","LU2357125470.USD","LU1366334651.USD","LU0149721374.USD","LU1008478684.HKD","BK4614","LU0593848301.USD","SG9999014898.SGD","LU1064131342.USD","LU0675040207.SGD","IE00B12V2V27.USD","LU1979443071.USD","LU2097828474.EUR","LU0345775950.USD","LU0348814723.USD","LU2477742899.HKD","LU1997244956.HKD","LU1691799644.USD","LU2580892862.HKD","IE00BZ08YT58.USD","LU0124384867.USD","LU1328277881.USD","LU0509642566.USD","JEMA","EEMX","LU0862451837.USD","IE00BFMHRM44.USD","LU2041044095.USD","LU0463099449.HKD","IE00B29SXG58.USD","IE00BYV24P56.USD","002028","LU0417516571.SGD","LU0051755006.USD","LU0107464264.USD","LU1235295612.USD","HK0000320264.USD","FPA","LU0456842615.SGD","BK0012","LU1439102457.SGD","BK0171","LU0254981946.USD","LU2247934214.USD","LU0348735423.USD","BK1238","LU0516422440.USD","LU0320764755.SGD","LU0577902611.USD","SGXZ81163826.USD","LU0011963245.USD","LU1769817096.USD","LU1721428347.USD","LU0918141887.USD","LU0359202008.SGD","BK0015","LU2506952253.HKD","IE00B8HQ1Z84.USD","IE00B031HY20.USD","LU1568876251.USD","LU0431992006.USD","LU0640798160.USD","LU2778985437.USD","00883","DRAG","SG9999000459.SGD","SG9999002950.SGD","SG9999001051.SGD","LU2213484517.USD","LU2449936058.SGD","BK0224","LU0348816934.USD","LU0588545730.USD","LU0737861699.HKD","HTCD.SI","LU0048575426.USD","SGXZ90724238.SGD","LU2187417386.USD","LU0106259558.USD","HK0000306701.USD","LU1813983027.USD","SG9999001226.SGD","LU2039709279.SGD","03750","SG9999015978.USD","LU0683595622.HKD","LU0128522744.USD","688981","LU1366334578.USD","BK4588","LU0828237940.HKD","BK0175","BK4543","LU0117844026.USD","LU0791591158.USD","LU0128525689.USD","LU2065169927.USD","SG9999014880.SGD","LU2360108059.USD","LU1997245177.USD","BK4526","LU0784639295.USD","LU1044875133.USD","LU1497733631.SGD","LU0516422952.EUR","LU0540923850.HKD","LU1868837722.USD","LU0588546209.SGD","LU1997245094.SGD","LU0072462343.USD","LU1522347837.USD","LU1634259391.SGD","LU0169518387.USD","BK0017","LU1282649141.HKD","LU2152927971.USD","AAXJ","300408","LU2264538146.SGD","IE00B0169N27.USD","IE00B5MMRT66.SGD","LU0499858438.USD","LU0553294199.USD","LU2106854487.HKD","LU2133065610.SGD","LU2251237488.HKD","LU1831875114.USD","LU2251237306.USD","LU0516422366.SGD","LU0061477393.USD","LU2097828714.EUR","LU0164880469.USD","IE00BQXX3D17.EUR","LU0315179316.USD","LU0823041008.USD","LU0405327494.USD","LU0173614495.USD","LU0456827905.SGD","LU1810669033.SGD","LU1051769294.HKD","LU2298064838.USD","LU0307460666.USD","SG9999007991.SGD","600938","LU0106252389.USD","LU0856984785.SGD","LU2051468812.USD","BABX","BK0132","LU0605514214.HKD","LU1568876335.HKD","LU1807302812.USD","LU0972618739.USD","BK4527","LU0868486357.SGD","LU0228659784.USD","LU0329678170.USD","LU2008162690.USD","LU1282648689.USD","LU1226288253.USD","00700","SG9999018857.SGD","LU0149534421.HKD","LU0700851271.USD","LU0823414478.USD","LU0048388663.USD","LU0985320562.USD","ALBmain","BK1531","LU1515016050.SGD","IE0008368742.USD","LU2348773727.SGD","LU0611395673.USD","LU0898667661.SGD","FDNI","LU1718418525.SGD","BK4502","LU1196710351.USD","BK1526","LU0175139822.USD","BK4533","LU1048596156.SGD","LU2476274308.USD","LU0054450605.USD","CLIX","LU1188198961.HKD","06951","LU0231483743.USD","LU2065170008.USD","LU0235996351.USD","BK0078","LU1978683503.SGD","LU2237443978.SGD","SGXZ99366536.SGD","LU1688375341.USD","LU2148611432.USD","LU2065171402.SGD","LU2580892789.USD","LU1580142542.USD","LU2351347302.SGD","SG9999002463.SGD","BK1618","BK1506","LU0345780521.USD","SG9999001689.USD","LU1655091616.SGD","BK1163","BK4585","LU0823414551.USD","BK4575","LU1720050803.USD","LU2293587155.HKD","LU1226287529.USD","LU0143863784.USD","LU2125910500.SGD","LU0865486749.SGD","LU0348805143.USD","LU2237443622.USD","LU2362541513.USD","ONLN","BK1592","LU0918141705.HKD","LU0417516738.SGD","LU0210527791.USD","LU0264606111.USD","LU0737861772.HKD","LU1939255532.USD","SGXZ81514606.USD","LU1226288170.HKD","LU0054237671.USD","LU2294711473.HKD","LU0588545904.SGD","BK0215","LU1675838814.USD","LU1242518857.USD","LU0345769128.USD","LU1211504680.USD","BABW","LU2929501877.USD","LU0572944931.SGD","SGXZ51526630.SGD","LU0488056044.USD","LU1048588211.SGD","LU1152091754.HKD","IE00BYTNYN87.SGD","SG9999015945.SGD","IE00B3M56506.USD","LU0039217434.USD","LU0441854154.USD","LU0650527681.SGD","LU0082770016.USD","SG9999000327.SGD","600519","LU2394011477.USD","SG9999001903.USD","BK0156","LU1051768304.USD","EMCS","HK0001040168.HKD","BK1591","LU0608807433.USD","LU1044876610.USD","LU2279701549.SGD","LU2257852520.SGD","BK0077","BK1528","LU0797268264.HKD","SG9999013353.USD","LU0572939691.SGD","LU0577902298.EUR","LU2125910849.SGD","LU1733274473.HKD","IE00BYQNZ168.SGD","HK0000352291.HKD","IE0009570106.USD","LU0266013472.USD","SG9999001069.SGD","LU0862451753.SGD","LU0499858602.USD","BK0109","LU1497734951.SGD","BKF","LU0823397103.USD","LU0786609619.USD","LU0878005551.USD","LU0266512473.USD","LU2242644610.SGD","LU2362541273.HKD","SG9999006597.SGD","EMC","IE00B8L5B284.USD","LU0823039010.USD","LU0648948544.HKD","IE0034224299.USD","LU0348783233.USD","LU1226287875.USD","IE0003851619.USD","LU0320764243.SGD","LU0634319403.HKD","IE0008369823.USD","LU0577902454.USD","LU0210533765.USD","LU0348827113.USD","LU3063872942.SGD","BK4534","LU0345776255.USD","GB00BDT5M118.USD","LU1039395188.USD","LU0531971595.HKD","LU0823413587.USD","LU1917777945.USD","LU0302445910.USD","LU0405327148.USD","LU0029875118.USD","LIT","LU0165289439.USD","LU1102505929.USD","IE00B031HW06.USD","EVS.SI","IE0003795394.USD","IE00BMPRXQ63.HKD","LU0049853897.USD","LU0661504455.SGD","LU0828237510.HKD","LU1146622755.USD","LU2237443895.HKD","LU1951186391.HKD","LU0348784397.USD","LU2360107325.USD","02899","IE00B067MR52.USD","LU0070217475.USD","XSOE","LU1629966141.USD","BK4579","LU1323998911.USD","LU0084288322.USD","IE00BQXX3F31.USD","LU2097828557.USD","LU0211331839.USD","HK0000914660.USD","LU0132412106.USD","LU1439103000.SGD","LU0315178854.USD","LU2237443465.HKD","LU1226288097.SGD","LU1785774172.SGD","LU0572940350.SGD","SG9999002828.SGD","BK0214","SG9999001846.SGD","LU0502904849.HKD","LU1242518931.SGD","LU0608807946.USD","LU1303224171.USD","BK0239","LU2506952410.USD","BK1594","LU1981816686.USD","LU0979878070.USD","LU1733274390.USD","LU0164865239.USD","BABU","LU1868838027.USD","LU0029874905.USD","LU2097828631.EUR","LU1064131003.USD","LU0828238088.HKD","SOCL","LU2097828805.USD","LU0516423174.USD","LU0348783662.USD","LU0456846285.SGD","LU1224709979.USD","LU0708995583.HKD","LU0949170772.SGD","LU0140636845.USD","ZIJMY","SG9999006514.SGD","BK4565","LU0545039389.USD","LU0561508036.HKD","LU0819121731.USD","BK4122","LU0326950275.SGD","BK4505","TCHmain","LU2294711713.HKD","300502","BK0231","LU0164872284.USD","00981","LU0314109678.HKD","CXSE","LU2289578879.USD","BK4503","BIDD","BK0196","LU0651947912.USD","LU1267930227.SGD","BK0167","LU0261950983.USD","LU0738911758.USD","LU1880383366.USD","LU2498475776.HKD","IE00B543WZ88.USD","LDEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651412701","title":"7月16日信立泰涨7.04%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651412701","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651412701?lang=zh_cn&edition=full","pubTime":"2026-07-16 16:27","pubTimestamp":1784190466,"startTime":"0","endTime":"0","summary":"证券之星消息，7月16日信立泰涨7.04%，收盘报41.37元，换手率5.91%，成交量65.88万手，成交额26.07亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共136家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值2.1116，较上一交易日上涨5.47%，近一年上涨15.79%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600026412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","159760","BK0028","BK0183","BK0187","BK0239","002294","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650183464","title":"7月10日信立泰涨5.45%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650183464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650183464?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:29","pubTimestamp":1783672188,"startTime":"0","endTime":"0","summary":"证券之星消息，7月10日信立泰涨5.45%，收盘报37.13元，换手率5.05%，成交量56.31万手，成交额20.59亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共136家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值1.8973，较上一交易日上涨2.81%，近一年上涨9.4%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000029050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002294","BK0187","BK0028","BK0196","BK0239","159760","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649991432","title":"信立泰（002294）披露SAL0167获得临床试验批准通知书，7月8日股价下跌7.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649991432","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649991432?lang=zh_cn&edition=full","pubTime":"2026-07-08 22:05","pubTimestamp":1783519517,"startTime":"0","endTime":"0","summary":"截至2026年7月8日收盘，信立泰报收于36.0元，较前一交易日下跌7.0%，最新总市值为401.33亿元。该股当日开盘38.02元，最高38.85元，最低35.8元，成交额达17.84亿元，换手率为4.32%。近日，深圳信立泰药业股份有限公司收到国家药品监督管理局核准签发的《临床试验批准通知书》，同意公司自主研发的创新药物SAL0167片开展高脂血症的临床试验。公司将按相关规定开展临床试验，后续进展将及时披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800042521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","002294","BK0196","BK0187","BK0239","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649969129","title":"信立泰(002294.SZ)：SAL0167获得临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2649969129","media":"智通财经网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649969129?lang=zh_cn&edition=full","pubTime":"2026-07-08 16:23","pubTimestamp":1783499036,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 信立泰 发布公告，公司收到国家药品监督管理局核准签发的《临床试验批准通知书》，同意公司自主研发的创新药物SAL0167片开展高脂血症的临床试验。SAL0167是公司具有自主知识产权的环肽药物。环肽具有对靶点的高亲和力和特异性，使SAL0167具备成为需要强效降脂的高胆固醇血症患者的优选方案的潜力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464669.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","BK0188","BMED","BK0028","BK0196","IBBQ","BK0183","002294","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648661312","title":"信立泰（002294）披露股票交易异常波动公告，7月3日股价上涨9.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648661312","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648661312?lang=zh_cn&edition=full","pubTime":"2026-07-03 22:02","pubTimestamp":1783087331,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，信立泰报收于40.08元，较前一交易日上涨9.99%，最新总市值为446.82亿元。近日，信立泰发布《股票交易异常波动公告》。公告显示，公司股票在2026年7月1日至7月3日连续三个交易日内日收盘价格涨幅偏离值累计超过20%，构成股票交易异常波动。公司、控股股东及实际控制人均不存在应披露而未披露的重大事项，且在股票异常波动期间未买卖公司股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300045112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002294","BK0187","BK0028","BK0196","BK0239","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648654941","title":"信立泰（002294）披露回购公司股份进展公告，7月1日股价上涨7.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648654941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648654941?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:10","pubTimestamp":1782915028,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，信立泰报收于34.2元，较前一交易日上涨7.24%，最新总市值为381.27亿元。近日，深圳信立泰药业股份有限公司披露《关于回购公司股份的进展公告》。公告显示，公司于2026年5月29日召开董事会，审议通过回购公司股份的议案，拟以自有资金及自筹资金回购A股股份，总金额不低于30,000万元且不超过50,000万元，回购价格不超过45元/股。本次回购符合相关法规及既定方案，后续将根据市场情况继续实施。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","002294","BK0187","BK0188","BK0239","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648516580","title":"7月1日信立泰涨7.24%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648516580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648516580?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:46","pubTimestamp":1782895600,"startTime":"0","endTime":"0","summary":"证券之星消息，7月1日信立泰涨7.24%，收盘报34.2元，换手率4.27%，成交量47.56万手，成交额15.69亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共136家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值1.8421，较上一交易日下跌0.29%，近一年上涨8.43%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100031474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0196","002294","BK0239","BK0188","159760","BK0028","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645095736","title":"每周股票复盘：信立泰（002294）首次回购股份999,600股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645095736","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645095736?lang=zh_cn&edition=full","pubTime":"2026-06-21 02:18","pubTimestamp":1781979491,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，信立泰报收于30.38元，较上周的31.3元下跌2.94%。本周，信立泰6月15日盘中最高价报31.9元。6月17日盘中最低价报29.85元，股价触及近一年最低点。信立泰当前最新总市值338.68亿元，在化学制药板块市值排名10/150，在两市A股市值排名633/5206。本次回购符合公司既定的回购方案及相关法律法规要求。回购股份将用于后期实施股权激励或员工持股计划。公司后续将根据市场情况在回购期限内继续实施回购计划，并及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100000591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002294","BK0183","BK0239","BK0196","BK0187","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644703956","title":"百亿基金经理调仓路径出炉：张坤增聘共管后新布局，葛兰谢治宇反向操作","url":"https://stock-news.laohu8.com/highlight/detail?id=2644703956","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644703956?lang=zh_cn&edition=full","pubTime":"2026-06-18 15:50","pubTimestamp":1781769000,"startTime":"0","endTime":"0","summary":"随着近期上市公司股东名单密集披露，百亿基金经理二季度调仓路径逐渐清晰。具体来看，易方达基金张坤的代表作基金——易方达蓝筹精选，在增聘基金经理杨思亮、何一铖共管后，首次建仓广深铁路。与此同时，中欧基金葛兰与兴证全球基金谢治宇在泰格医药上反向而行；景顺长城基金刘彦春与大成基金徐彦对晨光股份的调仓路径同样彼此背离，永赢基金高楠则对嘉益股份进行了微调。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606183776128689.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606183776128689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0174","LU1146622755.USD","BK0196","BK1583","BK0188","300347","BK0028","BK0077","LU1820825898.SGD","002294","03347","BK0239","BK0216","BK0187","BK1576","BK0183","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644674216","title":"信立泰（002294）披露首次回购公司股份公告，6月17日股价下跌0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644674216","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644674216?lang=zh_cn&edition=full","pubTime":"2026-06-17 22:47","pubTimestamp":1781707633,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘，信立泰报收于30.16元，较前一交易日下跌0.63%，最新总市值为336.23亿元。该股当日开盘30.21元，最高30.24元，最低29.85元，成交额达4.11亿元，换手率为1.23%。近日，深圳信立泰药业股份有限公司发布《关于首次回购公司股份的公告》。本次回购符合公司既定的回购方案及相关法律法规要求。回购股份将用于后期实施股权激励或员工持股计划。公司后续将根据市场情况在回购期限内继续实施回购计划，并及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700042464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002294","BK0188","BK0239","BK0196","BK0183","BK0028","BK0187"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787612554555,"stockEarnings":[{"period":"1week","weight":-0.0997},{"period":"1month","weight":-0.0177},{"period":"3month","weight":-0.0845},{"period":"6month","weight":-0.3587},{"period":"1year","weight":-0.3908},{"period":"ytd","weight":-0.3516}],"compareEarnings":[{"period":"1week","weight":-0.0253},{"period":"1month","weight":0.0178},{"period":"3month","weight":-0.0635},{"period":"6month","weight":-0.064},{"period":"1year","weight":0.0147},{"period":"ytd","weight":-0.0219}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳信立泰药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"74115人(较上一季度增加192.00%)","perCapita":"15038股","listingDate":"2009-09-10","address":"广东省深圳市福田区福保街道福保社区红柳道2号289数字半岛4层A区","registeredCapital":"111481万元","survey":" 深圳信立泰药业股份有限公司的主营业务是药品、医疗器械产品的研发、生产、销售，以及专利授权许可。公司的主要产品是心脑血管、肾脏、代谢类药物及医疗器械、骨科药物、头孢类抗生素及原料。","listedPrice":41.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"信立泰(002294)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供信立泰(002294)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"信立泰,002294,信立泰股票,信立泰股票老虎,信立泰股票老虎国际,信立泰行情,信立泰股票行情,信立泰股价,信立泰股市,信立泰股票价格,信立泰股票交易,信立泰股票购买,信立泰股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"信立泰(002294)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供信立泰(002294)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}